SEC Form 4 · accession 0001354488-17-000266
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Dillione
Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 15, 2017 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 18,738 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF2,F1 | $0.00 | Feb 14, 2017 | P | 3,472 | A | — | — | Common Stock | 3,472 | 3,472 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 4,143 | 4,143 | D |
| Stock Option (Right to Buy Common Stock)F3 | $3.03 | holding | — | — | — | — | Aug 11, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 1,415 | 1,415 | D |
| Stock Option (Right to Buy Common Stock)F4 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 95,000 | 95,000 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 3,831 | 3,831 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF1 | $0.00 | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
Explanation of responses
- F1Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F2These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for directors' fees.
- F3The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
- F4These options vest in full on the first anniversary of the date of grant.